Research and Markets ( http://www.researchandmarkets.com/re...ple_analysis_c : http://cts.businesswire.com/ct/CT?id...1157fdf47cd614 ) has announced the addition of the " Triple Analysis: Colorectal Cancer, Lung Cancer and Protein Kinase Inhibitors : http://cts.businesswire.com/ct/CT?id...41c400d0ffd73f " report to their offering. This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but
More...
More...